“…The disruption of sarcomere and contractile ultrastructure following EIMD leads to a well characterized sequelae of signs and symptoms including elevated serum creatine kinase (Newham et al, 1983a), inflammation and localized edema (Black et al, 2008;Black and McCully, 2008a), a decreased ability to generate force (Newham et al, 1983b), and heightened pain sensitivity-often termed delayed-onset muscle soreness (DOMS) (Newham et al, 1983b). A growing body of evidence clearly indicates EIMD negatively impacts endurance exercise performance as demonstrated by reductions in time-trial performance (Burt and Twist, 2011;Marcora and Bosio, 2007;Twist and Eston, 2009) and time-toexhaustion (Asp et al, 1998;Carmichael et al, 2006Carmichael et al, , 2010Davies et al, 2011aDavies et al, , 2008Davies et al, , 2009.…”